Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Cramer

Showing results (81-90 of 91) with videos related to

Pageof 10
Sort By:
Journal of Radiosurgery and SBRT|December 13, 2018
Potential prognostic markers for survival and neurologic death in patients with breast cancer brain metastases who receive upfront SRS aloneRachel F Shenker, Ryan T Hughes, Emory R McTyre, et al.
Journal of Radiosurgery and SBRT|December 18, 2025
External validation of a genomic signature for oligometastatic non-small cell lung cancerAriel R Choi, Ralph B D'Agostino, Claire M Lanier, et al.
International Journal of Radiation Oncology, Biology, Physics|July 3, 2020
Predictors of Adverse Radiation Effect in Brain Metastasis Patients Treated With Stereotactic Radiosurgery and Immune Checkpoint Inhibitor TherapyCorbin A Helis, Ryan T Hughes, Chase W Glenn, et al.
Frontiers in Endocrinology|October 2, 2024
Genomic signature for oligometastatic disease in non-small cell lung cancer patients with brain metastasesAriel R Choi, Ralph B D'Agostino, Michael K Farris, et al.
Head & Neck|September 1, 2022
Intensity-modulated radiotherapy with planned Gamma Knife radiosurgery boost for head and neck cancer with extensive disease in proximity to critical structuresJoshua C Farris, Cole R Steber, Paul J Black, et al.
Journal of Neuro-Oncology|May 25, 2026
Liquid biopsy-based genomic risk score to predict neurologic death in non-small cell lung cancer patientsSarah E Glynn, Ralph D'Agostino, Claire M Lanier, et al.
Neuroradiology|August 11, 2018
Glioblastoma radiomics: can genomic and molecular characteristics correlate with imaging response patterns?Michael H Soike, Emory R McTyre, Nameeta Shah, et al.
Patterns (New York, N.Y.)|November 24, 2022
A transformer-based deep-learning approach for classifying brain metastases into primary organ sites using clinical whole-brain MRI imagesQing Lyu, Sanjeev V Namjoshi, Emory McTyre, et al.
Cancers|March 28, 2025
Genomic Signature for Initial Brain Metastasis Velocity (iBMV) in Non-Small-Cell Lung Cancer Patients: The Elusive Biomarker to Predict the Development of Brain Metastases?Sarah E Glynn, Claire M Lanier, Ariel R Choi, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 19, 2019
Multi-institutional validation of brain metastasis velocity, a recently defined predictor of outcomes following stereotactic radiosurgeryEmory R McTyre, Michael H Soike, Michael Farris, et al.
Pageof 10

Showing results (81-90 of 91) with videos related to

Sort By:
Pageof 10
Journal of Radiosurgery and SBRT|December 13, 2018
Potential prognostic markers for survival and neurologic death in patients with breast cancer brain metastases who receive upfront SRS aloneRachel F Shenker, Ryan T Hughes, Emory R McTyre, et al.
Journal of Radiosurgery and SBRT|December 18, 2025
External validation of a genomic signature for oligometastatic non-small cell lung cancerAriel R Choi, Ralph B D'Agostino, Claire M Lanier, et al.
International Journal of Radiation Oncology, Biology, Physics|July 3, 2020
Predictors of Adverse Radiation Effect in Brain Metastasis Patients Treated With Stereotactic Radiosurgery and Immune Checkpoint Inhibitor TherapyCorbin A Helis, Ryan T Hughes, Chase W Glenn, et al.
Frontiers in Endocrinology|October 2, 2024
Genomic signature for oligometastatic disease in non-small cell lung cancer patients with brain metastasesAriel R Choi, Ralph B D'Agostino, Michael K Farris, et al.
Head & Neck|September 1, 2022
Intensity-modulated radiotherapy with planned Gamma Knife radiosurgery boost for head and neck cancer with extensive disease in proximity to critical structuresJoshua C Farris, Cole R Steber, Paul J Black, et al.
Journal of Neuro-Oncology|May 25, 2026
Liquid biopsy-based genomic risk score to predict neurologic death in non-small cell lung cancer patientsSarah E Glynn, Ralph D'Agostino, Claire M Lanier, et al.
Neuroradiology|August 11, 2018
Glioblastoma radiomics: can genomic and molecular characteristics correlate with imaging response patterns?Michael H Soike, Emory R McTyre, Nameeta Shah, et al.
Patterns (New York, N.Y.)|November 24, 2022
A transformer-based deep-learning approach for classifying brain metastases into primary organ sites using clinical whole-brain MRI imagesQing Lyu, Sanjeev V Namjoshi, Emory McTyre, et al.
Cancers|March 28, 2025
Genomic Signature for Initial Brain Metastasis Velocity (iBMV) in Non-Small-Cell Lung Cancer Patients: The Elusive Biomarker to Predict the Development of Brain Metastases?Sarah E Glynn, Claire M Lanier, Ariel R Choi, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 19, 2019
Multi-institutional validation of brain metastasis velocity, a recently defined predictor of outcomes following stereotactic radiosurgeryEmory R McTyre, Michael H Soike, Michael Farris, et al.
Pageof 10